[Eradication of Helicobacter pylori and use of antisecretory drugs--a population based study].
Lassen
Annmarie Touborg
AT
Odense Universitetshospital, Medicinsk Gastroenterologisk Afdeling S. annmarie.lassen@ouh.fyns-amt.dk
Hallas
Jesper
J
Schaffalitzky de Muckadell
Ove B
OB
D000328:Adult; D000863:Antacids / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D015331:Cohort Studies; D004359:Drug Therapy, Combination / Q000008:administration & dosage*; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006635:Histamine H2 Antagonists / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000382:microbiology; D054328:Proton Pump Inhibitors
D000863:Antacids; D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors